- ICH GCP
- US-Register für klinische Studien
- Klinische Studie NCT07872683
Maltodextrin Versus Sugar Water Carbohydrate Loading and Gastric Volume in Geriatric Lower Limb Orthopedic Surgery (CHO-GERIGAS)
Comparison of Maltodextrin and Sugar Water Carbohydrate Loading on Gastric Volume in Geriatric Patients Undergoing Lower Extremity Orthopedic Surgery
Before surgery, patients are asked to fast so the stomach is empty and stomach contents cannot enter the lungs during anesthesia. Long fasting is uncomfortable and can raise blood sugar and stress responses in older adults. Giving a carbohydrate drink up to 2 hours before surgery is part of enhanced recovery (ERAS) programs. It is not clear whether a maltodextrin drink or sugar water leaves less fluid in the stomach of older patients.
This randomized, double-blind study enrolls patients aged 60 years and older who are having elective lower limb orthopedic surgery under spinal or epidural anesthesia at Prof. Ngoerah General Hospital in Denpasar, Indonesia. Participants are assigned by chance to drink 400 mL of either a maltodextrin carbohydrate drink or sugar water 2 hours before anesthesia. The amount of fluid in the stomach is measured with bedside ultrasound before the drink and 2 hours after it. Blood glucose is measured before the drink, 2 hours after it and 6 hours after surgery. The neutrophil-lymphocyte ratio, a blood marker of inflammatory stress, is compared before surgery and 6 hours after surgery.
The results are intended to show which drink is better suited to older surgical patients and to support safer and more comfortable fasting practice.
Studienübersicht
Status
Bedingungen
Intervention / Behandlung
Detaillierte Beschreibung
Design. Double-blind, parallel-group randomized controlled trial with two arms and a 1:1 allocation ratio. Participants are recruited consecutively and allocated by computer-assisted block randomization. Setting: Central Surgical Installation and inpatient wards, Prof. Dr. I.G.N.G. Ngoerah General Hospital, Denpasar, Bali.
Procedure. Eligible patients are selected from the elective operating list the day before surgery and give written informed consent. All patients fast from solid food for 6 hours. In the reception area, age, sex, height, weight, body mass index, last meal and fasting duration are recorded. Baseline gastric ultrasound (right lateral decubitus, curvilinear probe) and capillary blood glucose are measured, and a blood sample for neutrophil and lymphocyte counts is taken. The participant then drinks 400 mL of the assigned drink within 15 to 30 minutes, 2 hours before anesthesia. Two hours later gastric ultrasound and blood glucose are repeated by the same operator. Anesthesia is neuraxial: spinal bupivacaine heavy 0.5% 10 to 12.5 mg at L3-L4, or epidural bupivacaine up to 0.25% in 10 to 12 mL. Six hours after the end of surgery, blood glucose and a complete blood count are repeated. Surgery type, duration and blood loss are taken from the electronic medical record.
Masking. The drinks are served in identical, opaque, unbranded, closed containers labeled A or B, with the same volume, temperature and timing, and drunk through a straw. The participant, the ultrasound operator who collects the data, and the data analyst do not know the allocation. The person who prepares and hands over the drinks knows it. The drinks differ in taste and appearance, so masking of participants relies on the opaque containers.
Hypothesis. The primary hypothesis is one-sided: gastric volume 2 hours after the maltodextrin drink is lower than after sugar water. The hypotheses for blood glucose and neutrophil-lymphocyte ratio are two-sided.
Sample size. The planned sample is 62 participants (31 per arm). The calculation used blood glucose as the driving outcome (28 per group, alpha 0.05, power 80%) plus 10% allowance for dropout.
Safety. Adverse events (allergy, nausea, bloating, regurgitation, hypotension, bradycardia) are managed by the anesthesia team, recorded, and reported to the hospital patient safety committee and the ethics committee.
Analysis. Normality is tested with Kolmogorov-Smirnov and variance homogeneity with Levene. Two groups are compared with the independent t-test or Mann-Whitney test. Repeated measurements use repeated-measures ANOVA or the Friedman test. Confounders are examined by stratification and a general linear model. Software: IBM SPSS Statistics 29.
Studientyp
Einschreibung (Geschätzt)
Phase
- Unzutreffend
Kontakte und Standorte
Studienkontakt
- Name: Burhan MD
- Telefonnummer: +62 822 7622 2247
- E-Mail: burhan.010@student.unud.ac.id
Studienorte
-
-
Bali
-
Denpasar, Bali, Indonesien, 80114
- Rekrutierung
- Prof. Dr. I.G.N.G. Ngoerah General Hospital (RSUP Prof. Dr. I.G.N.G. Ngoerah)
-
Kontakt:
- Burhan MD
- Telefonnummer: 08276222247
- E-Mail: burhan.010@student.unud.ac.id
-
-
Teilnahmekriterien
Zulassungskriterien
Studienberechtigtes Alter
Akzeptiert gesunde Freiwillige
Studienberechtigte Geschlechter
Beschreibung
Inclusion Criteria:
- Age 60 years or older with adequate cognitive function on brief cognitive screening
- ASA physical status II or III
- Elective lower extremity orthopedic surgery under neuraxial anesthesia
Exclusion Criteria:
- Emergency or urgent surgery
- Unstable hemodynamics
- Diagnosed gastrointestinal tract pathology
- History of bariatric surgery
- Dressing, wound cover or corset over the abdomen that prevents gastric ultrasound
- Use of a proton pump inhibitor, H2 antagonist or drug affecting gastrointestinal motility (for example metoclopramide, loperamide) in the past week
- Unable to lie in the lateral decubitus position
- Body mass index below 19 or 35 kg/m2 and above
- Refuses to take part after informed consent
Studienplan
Wie ist die Studie aufgebaut?
Designdetails
- Hauptzweck: Unterstützende Pflege
- Zuteilung: Zufällig
- Interventionsmodell: Parallele Zuordnung
- Maskierung: Verdreifachen
Waffen und Interventionen
Teilnehmergruppe / Arm |
Intervention / Behandlung |
|---|---|
|
Experimental: Maltodextrin Carbohydrate Loading
Participants drink 400 mL (4 packs of 100 mL) of a ready-to-drink clear maltodextrin carbohydrate beverage (Maltodex, about 200 kcal) within 15 to 30 minutes, 2 hours before anesthesia, after 6 hours of fasting from solid food. The drink is served in an opaque coded container with a straw. |
400 mL (4 x 100 mL) of ready-to-drink clear maltodextrin beverage (Maltodex, PT Finusoprima Farma Internasional). Per 100 mL: 50 kcal, 13 g carbohydrate of which 4 g sugars, 15 mg sodium, vitamin A and zinc at 15% of daily value each. Single dose, drunk within 15 to 30 minutes, 2 hours before anesthesia. Unlike the comparator it contains added vitamin A and zinc.
Andere Namen:
|
|
Aktiver Komparator: Sugar Water Carbohydrate Loading
Participants drink 400 mL of clear sugar water made with about 50 g of sucrose (table sugar) in drinking water (about 200 kcal) within 15 to 30 minutes, 2 hours before anesthesia, after 6 hours of fasting from solid food. The drink is served in an opaque coded container with a straw, identical to the other arm. |
400 mL of clear solution prepared by the hospital nutrition installation by dissolving about 50 g of sucrose (table sugar) in drinking water to a final volume of 400 mL (about 200 kcal, no fat, no protein). Single dose, drunk within 15 to 30 minutes, 2 hours before anesthesia.
Andere Namen:
|
Was misst die Studie?
Primäre Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
|---|---|---|
|
Gastric volume 2 hours after carbohydrate loading
Zeitfenster: 2 hours after finishing the study drink, before anesthesia
|
Gastric volume in mL estimated from bedside antral ultrasound in the right lateral decubitus position using the Perlas formula: volume (mL) = 27.0 + 14.6 x right-lateral antral cross-sectional area (cm2) - 1.28 x age (years). One operator, blinded to allocation. |
2 hours after finishing the study drink, before anesthesia
|
Sekundäre Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
|---|---|---|
|
Change in blood glucose from before loading to 2 hours after loading
Zeitfenster: Before the drink and 2 hours after the drink
|
Capillary blood glucose in mg/dL measured with an Accu-Chek glucometer before the drink and 2 hours after it. |
Before the drink and 2 hours after the drink
|
|
Change in neutrophil-lymphocyte ratio from before surgery to 6 hours after surgery
Zeitfenster: Last preoperative sample and 6 hours after the end of surgery
|
Neutrophil-lymphocyte ratio calculated from the complete blood count differential (Sysmex XN-3000) of the last preoperative sample and a sample taken 6 hours after the end of surgery. |
Last preoperative sample and 6 hours after the end of surgery
|
Mitarbeiter und Ermittler
Sponsor
Mitarbeiter
Ermittler
- Studienstuhl: Tjahya Aryasa, Sp.An-TI, Subsp.An.O.(K), Rumah Sakit Umum Pusat Sanglah Denpasar
- Studienstuhl: I Made Prema Putra, Sp.An-TI, Rumah Sakit Umum Pusat Sanglah Denpasar
- Hauptermittler: Lalu Reza Aldira Akbar, MD, Rumah Sakit Umum Pusat Sanglah Denpasar
Studienaufzeichnungsdaten
Haupttermine studieren
Studienbeginn (Tatsächlich)
Primärer Abschluss (Geschätzt)
Studienabschluss (Geschätzt)
Studienanmeldedaten
Zuerst eingereicht
Zuerst eingereicht, das die QC-Kriterien erfüllt hat
Zuerst gepostet (Tatsächlich)
Studienaufzeichnungsaktualisierungen
Letztes Update gepostet (Tatsächlich)
Letztes eingereichtes Update, das die QC-Kriterien erfüllt
Zuletzt verifiziert
Mehr Informationen
Begriffe im Zusammenhang mit dieser Studie
Schlüsselwörter
Zusätzliche relevante MeSH-Bedingungen
- Pathologische Prozesse
- Stoffwechselerkrankungen
- Erkrankungen der Atemwege
- Atemstörungen
- Störungen des Glukosestoffwechsels
- Pathologische Zustände, Anzeichen und Symptome
- Ernährungs- und Stoffwechselerkrankungen
- Entzündung
- Respiratorische Aspiration
- Hyperglykämie
- Natriumlactobionat -Saccharose -Lösung
Andere Studien-ID-Nummern
- 2026.02.1.0818
- 260805.358 (Andere Kennung: RSUP Prof. Dr. I.G.N.G. Ngoerah (Clinical Research Unit))
- 2754/UN14.2.2.VII.14/LT/2026 (Andere Kennung: Research Ethics Committee, Faculty of Medicine, Universitas Udayana)
Plan für individuelle Teilnehmerdaten (IPD)
Planen Sie, individuelle Teilnehmerdaten (IPD) zu teilen?
Arzneimittel- und Geräteinformationen, Studienunterlagen
Studiert ein von der US-amerikanischen FDA reguliertes Arzneimittelprodukt
Studiert ein von der US-amerikanischen FDA reguliertes Geräteprodukt
Diese Informationen wurden ohne Änderungen direkt von der Website clinicaltrials.gov abgerufen. Wenn Sie Ihre Studiendaten ändern, entfernen oder aktualisieren möchten, wenden Sie sich bitte an register@clinicaltrials.gov. Sobald eine Änderung auf clinicaltrials.gov implementiert wird, wird diese automatisch auch auf unserer Website aktualisiert .